A Supreme Court bench of justices Ranjan Gogoi and NV Ramana today stayed the 20 March Delhi high court order that restrained generic drug maker Glenmark Pharmaceuticals from manufacturing an anti-diabetes drug over which Merck allegedly held a patent, reported Mint.

Senior counsel Abhishek Manu Singhvi acted for Glenmark, with TR Andhyarujina acting for Merck. The next hearing will be on 28 April.